What is sarcoidosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Sarcoidosis

Sarcoidosis is a chronic multi-system inflammatory disease characterized by the formation of non-caseating (non-necrotic) granulomas that can affect virtually any organ, though most commonly involves the lungs and intrathoracic lymph nodes. 1

Core Pathophysiology

The disease involves an exaggerated immune response with specific histological features 2, 1:

  • Granuloma structure: Well-formed, concentrically arranged layers of immune cells with a central core of macrophage aggregates and multinucleated giant cells, surrounded by loosely organized lymphocytes (predominantly T cells) 2, 1
  • Immune mechanism: T cells play a central role with accumulation of CD4+ T cells, accompanied by release of IL-2 and formation of non-caseating granulomas 1
  • Necrosis pattern: Granulomas are typically non-necrotic, distinguishing them from tuberculosis, though variants (particularly nodular pulmonary sarcoidosis) can present with mixed necrotic and non-necrotic granulomas 2, 1

Epidemiology

The disease shows significant demographic variation 1:

  • Age-adjusted incidence is approximately 11 cases per 100,000 in Caucasians, with higher prevalence in northern Europe 1
  • In the United States, sarcoidosis is more prevalent in African Americans than whites 1
  • Women experience higher morbidity, mortality, and extrapulmonary involvement 1
  • African American women have 2.4 times higher mortality compared to matched cohorts without sarcoidosis 1

Clinical Manifestations by Organ System

Highly Probable Features for Diagnosis

Löfgren's syndrome is the most specific clinical presentation, characterized by bilateral hilar adenopathy with erythema nodosum and/or periarticular arthritis 2, 3

Skin manifestations 2, 1:

  • Lupus pernio (highly specific)
  • Maculopapular, erythematous, or violaceous lesions
  • Erythema nodosum
  • Subcutaneous nodules

Ocular involvement 2, 1:

  • Uveitis
  • Optic neuritis

Pulmonary Manifestations

The lungs are the most commonly affected organ 1, 4:

  • Bilateral hilar adenopathy on chest X-ray or CT 2, 3
  • Perilymphatic nodules on chest CT 2, 3
  • Dyspnea and chest pain 4

Extrapulmonary Manifestations

Cardiac involvement presents with cardiomyopathy, atrioventricular block, or ventricular tachycardia 1

Neurosarcoidosis occurs in approximately 5-15% of patients and can present with seizures due to parenchymal brain involvement or leptomeningeal disease 5

Hepatic involvement presents with elevated liver enzymes, hepatomegaly, and imaging showing enlargement or nodules 5

Upper respiratory tract involvement occurs in approximately 3-4% of patients with generalized disease 1

Bone involvement shows osteolysis, cysts/punched-out lesions, or trabecular pattern on imaging 2

Constitutional Symptoms

Common systemic symptoms include fatigue, fever, and weight loss 4, 6

Diagnostic Approach

The diagnosis of sarcoidosis requires three essential components 2, 5, 3:

  1. Compatible clinical and radiologic presentation
  2. Pathologic evidence of non-caseating granulomas
  3. Exclusion of alternative causes of granulomatous inflammation

Key Diagnostic Tests

Imaging studies 2, 5:

  • High-resolution CT scan of the chest showing bilateral hilar adenopathy and perilymphatic nodules
  • Gadolinium-enhanced MRI for CNS involvement showing leptomeningeal enhancement
  • PET scan showing parotid uptake
  • Cardiac MRI for suspected cardiac involvement

Laboratory testing 5:

  • Serum ACE level
  • Serum calcium and 24-hour urine calcium (hypercalcemia or hypercalciuria with abnormal vitamin D metabolism is highly probable for diagnosis) 2
  • Alkaline phosphatase
  • Complete blood count
  • Liver function tests

Tissue sampling 2, 5:

  • Biopsy of the most accessible affected organ to demonstrate non-caseating granulomas
  • Bronchoalveolar lavage showing lymphocytosis or elevated CD4:CD8 ratio 1

Critical Differential Diagnosis

Must exclude these alternative causes 2, 3:

  • Tuberculosis: Shows robust necrotizing granulomas with cavitation; requires AFB smear, culture, and interferon-gamma release assay 3
  • Histoplasmosis: Shows large acellular necrotizing granulomas; requires histoplasma urine/serum antigen and fungal cultures 3
  • Chronic beryllium disease: Has similar histology; blood lymphocyte proliferation test is diagnostic 2
  • Lymphoma: Shows monoclonal B-cell population on immunohistochemistry; requires flow cytometry and tissue biopsy 3
  • Brucellosis: Shows non-caseating granulomas with positive cultures or serology 3
  • Drug-induced sarcoid-like reactions: Associated with immune checkpoint inhibitors, anti-TNF-α, and other immunotherapeutics 2

Disease Course and Prognosis

Many patients with asymptomatic bilateral hilar lymphadenopathy have self-limited disease and do not require treatment 1, 5

The disease can undergo spontaneous regression, though chronic forms progressively threaten involved organs through fibrotic damage 4

Treatment Principles

Corticosteroids are the mainstay of treatment for symptomatic sarcoidosis, particularly with neurologic and hepatic involvement 5

Steroid-sparing agents like methotrexate are frequently needed for neurosarcoidosis with seizures 5

TNF inhibitors (infliximab, adalimumab) are effective for refractory cases 5

Monitoring: Regular assessment of liver function tests, complete blood count, and serum calcium every 6-12 months is recommended 5

References

Guideline

Sarcoidosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Distinguishing Lymphoma, Disseminated TB, Sarcoidosis, Histoplasmosis, and Brucellosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Sarcoidosis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.